Log in

NYSE:STJ - St Jude Medical Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume8.54 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company's product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
CUSIP79084910
Phone+1-651-7562000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

Receive STJ News and Ratings via Email

Sign-up to receive the latest news and ratings for STJ and its competitors with MarketBeat's FREE daily newsletter.


St Jude Medical (NYSE:STJ) Frequently Asked Questions

What is St Jude Medical's stock symbol?

St Jude Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "STJ."

Has St Jude Medical been receiving favorable news coverage?

Media headlines about STJ stock have trended somewhat positive on Wednesday, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. St Jude Medical earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave news stories about the medical technology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for St Jude Medical.

Who are some of St Jude Medical's key competitors?

What other stocks do shareholders of St Jude Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other St Jude Medical investors own include Gilead Sciences (GILD), Wheaton Precious Metals (WPM), Celgene (CELG), Abbott Laboratories (ABT), Eli Lilly And Co (LLY), Johnson & Johnson (JNJ), Alphabet (GOOG), Edwards Lifesciences (EW), Palo Alto Networks (PANW) and Twitter (TWTR).

What is St Jude Medical's official website?

The official website for St Jude Medical is http://www.sjm.com/.

How can I contact St Jude Medical?

St Jude Medical's mailing address is 1 Saint Jude Medical Dr, SAINT PAUL, MN 55117-1789, United States. The medical technology company can be reached via phone at +1-651-7562000.


MarketBeat Community Rating for St Jude Medical (NYSE STJ)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  782 (Vote Outperform)
Underperform Votes:  779 (Vote Underperform)
Total Votes:  1,561
MarketBeat's community ratings are surveys of what our community members think about St Jude Medical and other stocks. Vote "Outperform" if you believe STJ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STJ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/11/2019 by MarketBeat.com Staff

Featured Article: What is a balanced fund?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel